Increased insulin clearance in peroxisome proliferator-activated receptor γ2 Pro12Ala

被引:26
作者
Tschritter, O [1 ]
Fritsche, A [1 ]
Stefan, N [1 ]
Haap, M [1 ]
Thamer, C [1 ]
Bachmann, O [1 ]
Dahl, D [1 ]
Maerker, E [1 ]
Teigeler, A [1 ]
Machicao, F [1 ]
Häring, H [1 ]
Stumvoll, M [1 ]
机构
[1] Univ Tubingen, Med Klin, Abt Endokrinol Stoffwechsel & Pathochem, D-72076 Tubingen, Germany
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2003年 / 52卷 / 06期
关键词
D O I
10.1016/S0026-0495(03)00071-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPARgamma2) is associated with reduced risk for type 2 diabetes. Although increased insulin sensitivity of glucose disposal and lipolysis has been reported, the exact mechanism by which the risk reduction is conferred is not clear. Because the conclusion of greater insulin sensitivity hinged upon lower insulin levels in some studies, it is possible that more efficient insulin clearance is involved. We therefore estimated insulin clearance during a euglycemic hyperinsulinemic clamp (insulin infusion rate divided by steady-state insulin concentration, 229 normal glucose tolerant [NGT] subjects), an oral glucose tolerance test (OGTT) (mean C-peptide divided by mean insulin concentrations, 406 NGT, 54 impaired glucose tolerant or mildly diabetic subjects), and a hyperglycemic clamp (120 minutes, 10 mmol/L, C-peptide divided by insulin in the steady-state, 56 NGT subjects). In the carriers of the Ala allele (prevalence similar to24%), insulin clearance in all 3 protocols was significantly greater (similar to 10%), than in controls. While the results from the euglycemic clamp reflect both hepatic and peripheral insulin clearance; those from the OGTT and the hyperglycemic clamp reflect mainly hepatic insulin extraction. Free fatty acids (FFA) during the steady state of the euglycemic hyperinsulinemic clamp were significantly lower in carriers of the Ala allele (26 +/- 5 mumol/L) than in controls (46 +/- 3 mumol/L, P = .02). In conclusion, the Pro12Ala polymorphism is associated with increased insulin clearance. This could be the result of reduced FFA delivery, which has been shown to improve hepatic insulin removal and sensitivity. Because PPARgamma2 is mainly expressed in adipose tissue, one of the main regulatory effects of the polymorphism may well be the more efficient suppression of (possibly intra-abdominal) lipolysis. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:778 / 783
页数:6
相关论文
共 41 条
  • [1] The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
    Altshuler, D
    Hirschhorn, JN
    Klannemark, M
    Lindgren, CM
    Vohl, MC
    Nemesh, J
    Lane, CR
    Schaffner, SF
    Bolk, S
    Brewer, C
    Tuomi, T
    Gaudet, D
    Hudson, TJ
    Daly, M
    Groop, L
    Lander, ES
    [J]. NATURE GENETICS, 2000, 26 (01) : 76 - 80
  • [2] PPARγ, the ultimate thrifty gene
    Auwerx, J
    [J]. DIABETOLOGIA, 1999, 42 (09) : 1033 - 1049
  • [3] Insulin sensitivity of suppression of endogenous glucose production is the single most important determinant of glucose tolerance
    Båvenholm, PN
    Pigon, J
    Östenson, CG
    Efendic, S
    [J]. DIABETES, 2001, 50 (06) : 1449 - 1454
  • [4] Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations
    Beamer, BA
    Yen, CJ
    Andersen, BE
    Muller, D
    Elahi, D
    Cheskin, LJ
    Andres, R
    Roth, J
    Shuldiner, AR
    [J]. DIABETES, 1998, 47 (11) : 1806 - 1808
  • [5] The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
    Berg, AH
    Combs, TP
    Du, XL
    Brownlee, M
    Scherer, PE
    [J]. NATURE MEDICINE, 2001, 7 (08) : 947 - 953
  • [6] Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein?
    Bergman, RN
    [J]. DIABETOLOGIA, 2000, 43 (07) : 946 - +
  • [7] Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
    Boden, G
    [J]. DIABETES, 1997, 46 (01) : 3 - 10
  • [8] FAT-METABOLISM IN HUMAN OBESITY
    CAMPBELL, PJ
    CARLSON, MG
    NURJHAN, N
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (04): : E600 - E605
  • [9] The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects
    Chen, XH
    Iqbal, N
    Boden, G
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (03) : 365 - 372
  • [10] Endogenous glucose production is inhibited by the adipose-derived protein Acrp30
    Combs, TP
    Berg, AH
    Obici, S
    Scherer, PE
    Rossetti, L
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (12) : 1875 - 1881